ILOMASTAT
OKother
This appears to be a proprietary ingredient or a misspelling.
Regulatory Info
Status: Approved
Restrictions: Butanediamide, N4-hydroxy-N1-((1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-, (2R)-
This appears to be a proprietary ingredient or a misspelling.